Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?

BACKGROUND: Epidemiologic studies have suggested that hypertriglyceridemia and insulin resistance are related to the development of colon cancer. Nuclear peroxisome proliferator-activated receptors (PPAR), which play a central role in lipid and glucose metabolism, had been hypothesized as being invo...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Tenenbaum, Alexander, Boyko, Valentina, Fisman, Enrique Z, Goldenberg, Ilan, Adler, Yehuda, Feinberg, Micha S, Motro, Michael, Tanne, David, Shemesh, Joseph, Schwammenthal, Ehud, Behar, Solomon
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2008
Teme:
Original Investigation
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2440374/
https://ncbi.nlm.nih.gov/pubmed/18565233
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2840-7-18
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki